Range
1.71 - 1.75
Vol / Avg.
61.3K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
23.6M
Payout Ratio
-
Open
1.73
P/E
-
EPS
0
Shares
13.6M
Outstanding
13.6M
Total Float
13M
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Earnings

see more
H1 2021Est.ActualSurprise
EPS-0.540
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Altamira Therapeutics Questions & Anwsers

Q

How do I buy Altamira Therapeutics (CYTO) stock?

A

You can purchase shares of Altamira Therapeutics (NASDAQ: CYTO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Altamira Therapeutics's (CYTO) competitors?

A

There are no as such competitors for Altamira Therapeutics.

Q

What is the target price for Altamira Therapeutics (CYTO) stock?

A

There is no analysis for Altamira Therapeutics

Q

Current Stock Price for Altamira Therapeutics (CYTO)?

A

The stock price for Altamira Therapeutics (NASDAQ: CYTO) is $1.73 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Altamira Therapeutics (CYTO) pay a dividend?

A

There are no upcoming dividends for Altamira Therapeutics.

Q

When is Altamira Therapeutics (NASDAQ:CYTO) reporting earnings?

A

Altamira Therapeutics’s $H1 earnings are confirmed for after-market on $September 8, 2021.

Q

Is Altamira Therapeutics (CYTO) going to split?

A

There is no upcoming split for Altamira Therapeutics.

Q

What sector and industry does Altamira Therapeutics (CYTO) operate in?

A

Altamira Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.